|
ACOX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.66779999999767E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.580720E-04 |
| Normal-vs-Stage2 |
1.614220E-04 |
| Normal-vs-Stage3 |
5.660200E-03 |
| Normal-vs-Stage4 |
2.746300E-02 |
| Stage1-vs-Stage2 |
7.429900E-02 |
| Stage1-vs-Stage3 |
4.587400E-01 |
| Stage1-vs-Stage4 |
2.911400E-01 |
| Stage2-vs-Stage3 |
4.250500E-02 |
| Stage2-vs-Stage4 |
3.074300E-02 |
| Stage3-vs-Stage4 |
7.532800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.762990E-04 |
| Normal-vs-AfricanAmerican |
2.631500E-04 |
| Normal-vs-Asian |
4.250100E-02 |
| Caucasian-vs-AfricanAmerican |
3.303700E-02 |
| Caucasian-vs-Asian |
3.135400E-01 |
| AfricanAmerican-vs-Asian |
8.701600E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.183300E-03 |
| Normal-vs-Female |
4.32750000000093E-05 |
| Male-vs-Female |
5.661200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.08460000000233E-05 |
| Normal-vs-Age(41-60Yrs) |
4.187800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.760720E-03 |
| Normal-vs-Age(81-100Yrs) |
6.325400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.074600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.917200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.812800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.984400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.389800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.389000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.482000E-01 |
| Classical-VS-Follicular |
1.160830E-01 |
| Classical-VS-Other |
4.224400E-01 |
| Classical-VS-Normal |
3.09300000000956E-06 |
| Tall-VS-Follicular |
9.134400E-01 |
| Tall-VS-Other |
8.212000E-01 |
| Tall-VS-Normal |
4.700200E-02 |
| Follicular-VS-Other |
7.963000E-01 |
| Follicular-VS-Normal |
1.610080E-02 |
| Other-VS-Normal |
5.534000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.796520E-04 |
| Normal-vs-N1 |
4.975000E-01 |
| N0-vs-N1 |
2.392000E-02 |
|
|
